MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States

    NEXT STORY
    Checkpoint Therapeutics Announces Confirmation of Registration Path for Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
    PREV STORY
    Recombinant Vaccines Market to Reach $21 Billion by 2026; Increasing Number of Regulatory Approvals to Aid Growth, says Fortune Business Insights™
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Pluristem Expands its Compassionate Use Program: Treated First COVID-19 Patient in U.S. Under FDA Single Patient Expanded Access Program

    author_avatar
    NASDAQ Market News

    CELYAD S.A.: Celyad Announces Results for the CHART-1 Phase III Clinical Trial Evaluating C-Cure(R) Cell Therapy

    A statistically-significant difference on the primary endpoint was not reached; however, a positive trend ...

    author_avatar
    NASDAQ Market News

    Elder Berry Adulteration Documented by New Botanical Adulterants Prevention Program Article

    author_avatar
    NASDAQ Market News